Global Genetic Testing Market

Global Genetic Testing Market Size, Share, Growth Analysis, By Type(Predictive & presymptomatic testing, carrier testing), By Technology(Cytogenetic testing, molecular testing), By Application(Cancer diagnosis, genetic disease diagnosis) - Industry Forecast 2024-2031


Report ID: SQMIG35H2074 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 94 | Figures: 76

Global Genetic Testing Market Insights

Genetic Testing Market size was valued at USD 6082.85 million in 2019 and is poised to grow from USD 7421.08 million in 2023 to USD 35.34 million by 2031, growing at a CAGR of 22% in the forecast period (2024-2031).

Genetic testing is a type of medical examination that examines a person's DNA to detect genetic variations in certain disorders. A suspected genetic disease can be confirmed by its findings. It helps determine a person's having or developing a genetic condition. It involves monitoring proteins, chromosomes, and genes for changes. Genetic variations (mutations) that increase the risk of a genetic disorder can be detected by gene testing. It is voluntary and offers benefits, as well as restrictions and risks. It involves dissecting tissue or cells to look for changes in genes, chromosomes, or proteins. In addition, tumor tissue can be used to diagnose cancer.

The development of new test kits as a result of technological advancements and the increased prevalence of genetic and chronic diseases are the two main factors driving the global market. Increasing public awareness about the availability of advanced diagnostic procedures has increased the need for genetic testing. Additionally, the growing geriatric population is expected to fuel market growth in the near future. The United Nations estimates that in 2019 there were 382 million individuals worldwide who were 60 years of age or older, and this figure is expected to increase to 2.1 billion by 2031. Because of the increased risk of chronic diseases in older individuals, genetic testing may be more important. Rising consumer healthcare expenditure, increasing disposable income, technological development, and availability of these services are the major factors driving the growth of the global genetic testing market.

The adoption of genetic testing among populations around the world is being fueled by increasing government efforts to increase knowledge about it. In addition, the presence of several key market players and their significant investment in R&D activities has led to product design innovation, improved delivery, and increased product quality. Owing to their low cost, direct-to-consumer genetic testing kits are increasingly being used by the general public, which is expected to accelerate the growth of the global market. In addition, people can purchase DNA test kits from major Internet retailers such as Ancestry.com and 23andMe to have them delivered to their homes. People are increasingly using self-testing websites due to the ease and convenience of self-testing kits. Additionally, increasing marketing strategies used by online businesses have contributed greatly to increasing knowledge about genetic testing. For example, in 2019, Ancestry.com spent US$109.0 million on TV advertising in the US. these ads had a huge impact on the global market.

However, it can be expensive and may not be covered by some health insurance plans. Stringent regulation policies related to the testing are the factors that may hamper the market growth.

US Genetic Testing Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Genetic Testing Market size was valued at USD 6082.85 million in 2019 and is poised to grow from USD 7421.08 million in 2023 to USD 35.34 million by 2031, growing at a CAGR of 22% in the forecast period (2024-2031).

The genetic testing market is fragmented and highly competitive. Key industry players are focused on product developments, new product launches, and geographical expansions to gain a significant amount of market share. ' Illumina, Inc. ', ' Thermo Fisher Scientific, Inc. ', ' Qiagen N.V. ', ' Myriad Genetics, Inc. ', ' Invitae Corporation ', ' BGI Group ', ' Eurofins Scientific SE ', ' F. Hoffmann-La Roche AG ', ' PerkinElmer, Inc. ', ' Becton, Dickinson and Company ', ' Agilent Technologies, Inc. ', ' Bio-Rad Laboratories, Inc. ', ' 23andMe, Inc. ', ' Ancestry.com LLC ', ' GeneDx, Inc. ', ' Counsyl, Inc. ', ' Natera, Inc. ', ' Veracyte, Inc. ', ' Guardant Health, Inc. ', ' Caris Life Sciences. '

Genetic diseases can cause very serious health problems that are life-threatening. In extreme cases, these disorders can cause a miscarriage of the affected fetus or baby. Demand for genetic testing is increasing as genetic diseases and birth defects become more common. According to the World Health Organization publication, Genetic Disorders and Congenital Malformations: Strategies to Reduce the Burden in the Region, 2022, genetic and congenital disorders are the primary causes of pregnancy and neonatal death in many countries in the region. Birth defects are currently the leading cause of infant mortality in the United Arab Emirates, with Bahrain being in second place behind Kuwait, Oman, and Qatar. Hence, this is driving the demand for the genetic testing market.

The primary reason driving the growth of the global market is the rising prevalence of genetic and chronic illnesses worldwide. The execution of several positive initiatives by government agencies and non-governmental organizations (NGOs) aimed at raising public awareness of genetic testing further supports this. Accordingly, a further element promoting expansion is the widespread use of the testing in pharmacogenomics, or drug-gene testing, which examines how the body reacts to specific medications after they interact with hereditary genes. The rapid emergence of the coronavirus disease (COVID-19) pandemic has also prompted wider use of virtual testing and home testing kits for sample collection purposes, which is driving market expansion. The development of DTC-GT (Direct-to-Consumer Genetic Testing) kits and the enormous technological advances in genetic testing methods are further boosting the market's expansion. A favorable outlook for the market is being created by other factors including growing investments in research and development (R&D) activities in the medical sciences and strategic partnerships among leading manufacturers for the introduction of enhanced personalized genetic testing kits.

North America dominated the global genetic testing market in terms of revenue in 2020 and is expected to maintain its dominance during the forecast period. This is due to the increasing awareness of the population about the benefits of the testing among consumers. In addition, the widespread adoption of genetic testing kits among the population has been aided by easy access to self-testing kits through online websites in countries such as the US. Additionally, the market has grown tremendously due to the increasing prevalence of numerous chronic diseases among the majority of the population and rising consumer spending on healthcare. In the coming years, the market is predicted to be driven by the growing aging population in the US. Additionally, increasing acceptance and usage of formulated drugs among the population is expected to drive market growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Genetic Testing Market

Product ID: SQMIG35H2074

$5,300
BUY NOW GET FREE SAMPLE